EBS
Emergent BioSolutions Inc.Healthcare · $358M market cap
Verdict
Share price
$6.33
close of Oct 3, 2026
Fair value
$19.56
Sticker Price
Payback Price
$7.82
buy price
EBS is On Sale: at $6.33 it trades 19% below its buy price (Payback Price) of $7.82 and 68% below its fair value of $19.56. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow EBS
Get notified when it reaches its buy price of $7.82. Free.
Create a free accountInsider activity
Since Jul 1, 2026: no open-market purchases and 1 sale worth $25K. Why purchases matter
Sales
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CBRNE) incidents, emerging infectious diseases, travel-related health…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works